bnp | 7570
BNP
Keywords
B-type natriuretic peptide, BNP, Cardiomyopathy, Heart failure, myocardial markers
| Material |
|
|
| Note |
The assay is disrupted by biotin. Intake of biotin can cause false-low results. | Limitation for reimbursement by the health insurance company: clarification of the acute dyspnea to exclude acute or chronic heart failure; not for therapy monitoring. |
|
| Min. quantity | 1 mL | |
| Stability | 1 day / 2-8°C; 9 months / -20°C | |
| Duration | 2 hours | |
| Frequency | continually, 7 days per week | |
| Method | Chemiluminescent Immuno Assay | |
| Price | CHF 63.00 | |
| Tariff | 63.00 TP | |
| LA position | 1576.00 | |
| Designation | Natriuretisches Peptid (BNP, NT-proBNP) |
Reference values
| Value | Sex |
|---|---|
| . ng/L | f+m |
Team of consultants
|
MD
Uta Deus
FMH General internal medicine, FAMH Specialist in laboratory medicine
|
FMH General internal medicine, FAMH Specialist in laboratory medicine | T |
|
|
PhD
Maurus Curti
FAMH Specialist in laboratory medicine
|
FAMH Specialist in laboratory medicine | T |
|
|
Dr. sc. nat.
Corinne Ruppen
FAMH Specialist in laboratory medicine, main field clinical chemistry
|
FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|
|
Dr. rer. nat.
Kristina Vollmer
FAMH Specialist in laboratory medicine, main field clinical chemistry
|
FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|